FDA Expands Pfizer COVID Booster, Opens Extra Dose To Age 16 And Up

The FDA has extended emergency use authorization for Pfizer's COVID-19 booster to include 16 and 17-year-olds, following a study showing increased protection against the Omicron variant. Despite this, only 25% of the eligible U.S. population has received a booster. Experts emphasize the importance of boosters and masks, particularly N95s, in combating the variant. The World Health Organization warns Omicron could alter the pandemic's trajectory, and experts call for redefining 'fully vaccinated' to mean three doses.

What new insight or understanding did you gain from this video?

Evaluate responses using AI:

OFF